Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christoph Reiners

Showing results (101-110 of 133) with videos related to

Pageof 14
Sort By:
Nuclear Medicine and Biology|January 18, 2015
Prognostic value of positron emission tomography-assessed tumor heterogeneity in patients with thyroid cancer undergoing treatment with radiopeptide therapyConstantin Lapa, Rudolf A Werner, Jan-Stefan Schmid, et al.
Frontiers in Endocrinology|November 16, 2020
Feasibility Study Shows Multicenter, Observational Case-Control Study Is Practicable to Determine Risk of Secondary Breast Cancer in Females With Differentiated Thyroid Carcinoma Given Radioiodine Therapy in Their Childhood or Adolescence; Findings Also Suggest Possible Fertility Impairment in Such PatientsValentina Drozd, Rita Schneider, Tamara Platonova, et al.
Radiation Protection Dosimetry|September 25, 2016
The First Meeting of the WHO Guideline Development Group for the Revision of the WHO 1999 Guidelines for Iodine Thyroid BlockingChristoph Reiners, Rita Schneider, Makoshi Akashi, et al.
The Journal of Clinical Endocrinology and Metabolism|April 24, 2013
[¹²³I]Iodometomidate imaging in adrenocortical carcinomaMichael C Kreissl, Andreas Schirbel, Martin Fassnacht, et al.
The Journal of Clinical Endocrinology and Metabolism|February 22, 2013
Functional characterization of adrenal lesions using [123I]IMTO-SPECT/CTStefanie Hahner, Michael C Kreissl, Martin Fassnacht, et al.
Radiation Oncology (London, England)|June 23, 2012
Combination of peptide receptor radionuclide therapy with fractionated external beam radiotherapy for treatment of advanced symptomatic meningiomaMichael C Kreissl, Heribert Hänscheid, Mario Löhr, et al.
Frontiers in Endocrinology|August 6, 2020
Breast Cancer After Treatment of Differentiated Thyroid Cancer With Radioiodine in Young Females: What We Know and How to Investigate Open Questions. Review of the Literature and Results of a Multi-Registry SurveyChristoph Reiners, Rita Schneider, Tamara Platonova, et al.
European Journal of Endocrinology|February 7, 2004
Follow-up of low-risk patients with differentiated thyroid carcinoma: a European perspectiveMartin Schlumberger, Gertrud Berg, Ohad Cohen, et al.
European Journal of Nuclear Medicine and Molecular Imaging|March 23, 2022
Second primary malignancies induced by radioactive iodine treatment of differentiated thyroid carcinoma - a critical review and evaluation of the existing evidenceMaximilian J Reinecke, Gerrit Ahlers, Andreas Burchert, et al.
Kidney International|March 29, 2002
L-arginine deficiency and supplementation in experimental acute renal failure and in human kidney transplantationLothar Schramm, Mylinh La, Ekkehart Heidbreder, et al.
Pageof 14

Showing results (101-110 of 133) with videos related to

Sort By:
Pageof 14
Nuclear Medicine and Biology|January 18, 2015
Prognostic value of positron emission tomography-assessed tumor heterogeneity in patients with thyroid cancer undergoing treatment with radiopeptide therapyConstantin Lapa, Rudolf A Werner, Jan-Stefan Schmid, et al.
Frontiers in Endocrinology|November 16, 2020
Feasibility Study Shows Multicenter, Observational Case-Control Study Is Practicable to Determine Risk of Secondary Breast Cancer in Females With Differentiated Thyroid Carcinoma Given Radioiodine Therapy in Their Childhood or Adolescence; Findings Also Suggest Possible Fertility Impairment in Such PatientsValentina Drozd, Rita Schneider, Tamara Platonova, et al.
Radiation Protection Dosimetry|September 25, 2016
The First Meeting of the WHO Guideline Development Group for the Revision of the WHO 1999 Guidelines for Iodine Thyroid BlockingChristoph Reiners, Rita Schneider, Makoshi Akashi, et al.
The Journal of Clinical Endocrinology and Metabolism|April 24, 2013
[¹²³I]Iodometomidate imaging in adrenocortical carcinomaMichael C Kreissl, Andreas Schirbel, Martin Fassnacht, et al.
The Journal of Clinical Endocrinology and Metabolism|February 22, 2013
Functional characterization of adrenal lesions using [123I]IMTO-SPECT/CTStefanie Hahner, Michael C Kreissl, Martin Fassnacht, et al.
Radiation Oncology (London, England)|June 23, 2012
Combination of peptide receptor radionuclide therapy with fractionated external beam radiotherapy for treatment of advanced symptomatic meningiomaMichael C Kreissl, Heribert Hänscheid, Mario Löhr, et al.
Frontiers in Endocrinology|August 6, 2020
Breast Cancer After Treatment of Differentiated Thyroid Cancer With Radioiodine in Young Females: What We Know and How to Investigate Open Questions. Review of the Literature and Results of a Multi-Registry SurveyChristoph Reiners, Rita Schneider, Tamara Platonova, et al.
European Journal of Endocrinology|February 7, 2004
Follow-up of low-risk patients with differentiated thyroid carcinoma: a European perspectiveMartin Schlumberger, Gertrud Berg, Ohad Cohen, et al.
European Journal of Nuclear Medicine and Molecular Imaging|March 23, 2022
Second primary malignancies induced by radioactive iodine treatment of differentiated thyroid carcinoma - a critical review and evaluation of the existing evidenceMaximilian J Reinecke, Gerrit Ahlers, Andreas Burchert, et al.
Kidney International|March 29, 2002
L-arginine deficiency and supplementation in experimental acute renal failure and in human kidney transplantationLothar Schramm, Mylinh La, Ekkehart Heidbreder, et al.
Pageof 14